These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35147419)

  • 1. Evaluation of Interactions between SARS-CoV-2 RBD and Full-Length ACE2 with Coarse-Grained Molecular Dynamics Simulations.
    Ma B; Zhang Z; Li Y; Lin X; Gu N
    J Chem Inf Model; 2022 Feb; 62(4):936-944. PubMed ID: 35147419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-Atom Simulations of Human ACE2-Spike Protein RBD Complexes for SARS-CoV-2 and Some of its Variants: Nature of Interactions and Free Energy Diagrams for Dissociation of the Protein Complexes.
    Dutta S; Panthi B; Chandra A
    J Phys Chem B; 2022 Jul; 126(29):5375-5389. PubMed ID: 35833966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.
    Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S
    Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor.
    Delgado JM; Duro N; Rogers DM; Tkatchenko A; Pandit SA; Varma S
    Proteins; 2021 Sep; 89(9):1134-1144. PubMed ID: 33864655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?
    Nguyen HL; Lan PD; Thai NQ; Nissley DA; O'Brien EP; Li MS
    J Phys Chem B; 2020 Aug; 124(34):7336-7347. PubMed ID: 32790406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study.
    Dehury B; Raina V; Misra N; Suar M
    J Biomol Struct Dyn; 2021 Nov; 39(18):7231-7245. PubMed ID: 32762417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2.
    Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I
    J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation.
    Rui L; Haonan L; Wanyi C
    Biophys Chem; 2020 Dec; 267():106472. PubMed ID: 32916377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tinocordiside from
    Balkrishna A; Pokhrel S; Varshney A
    Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
    Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
    J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective.
    Borkotoky S; Dey D; Hazarika Z
    Mol Biol Rep; 2023 Mar; 50(3):2713-2721. PubMed ID: 36562937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
    Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
    J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.
    Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
    Biophys J; 2021 Mar; 120(6):1011-1019. PubMed ID: 33607086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike.
    Mehdipour AR; Hummer G
    Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33903171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 omicron RBD forms a weaker binding affinity to hACE2 compared to Delta RBD in
    Le HT; Tran LH; Phung HTT
    J Biomol Struct Dyn; 2024 May; 42(8):4087-4096. PubMed ID: 37345564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
    Lata S; Akif M
    J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2
    Li Z; Zhang JZH
    Phys Chem Chem Phys; 2021 Jun; 23(25):13926-13933. PubMed ID: 34137759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key residues of the receptor binding domain in the spike protein of SARS-CoV-2 mediating the interactions with ACE2: a molecular dynamics study.
    Yang Y; Zhang Y; Qu Y; Zhang C; Liu XW; Zhao M; Mu Y; Li W
    Nanoscale; 2021 May; 13(20):9364-9370. PubMed ID: 33999091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.